| Literature DB >> 16098464 |
Madhu Macrae1, Richard M Neve, Pablo Rodriguez-Viciana, Christopher Haqq, Jennifer Yeh, Chira Chen, Joe W Gray, Frank McCormick.
Abstract
The EphA2 receptor tyrosine kinase is frequently overexpressed in many cancers, including 40% of breast cancers. Here, we show that EphA2 is a direct transcriptional target of the Ras-Raf-MAPK pathway and that ligand-stimulated EphA2 attenuates the growth factor-induced activation of Ras. Thus, a negative feedback loop is created that regulates Ras activity. Interestingly, the expression of EphA2 and ephrin-A1 is mutually exclusive in a panel of 28 breast cancer cell lines. We show that the MAPK pathway inhibits ephrin-A1 expression, and the ligand expression inhibits EphA2 levels contributing to the receptor-ligand reciprocal expression pattern in these cell lines. Our results suggest that an escape from the negative effects of this interaction may be important in the development of cancer.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16098464 DOI: 10.1016/j.ccr.2005.07.005
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743